守护者健康
GH
158.60
-7.28
-4.39%
守护者健康
US · GH
#820 按市值排名
上市于 2018
158.60
-7.28
-4.39%
实时 - 追踪5344个代码 - 心跳于206秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例下降了1.0个百分点。
机构持股
- 机构持股比例
- 100.95% -0.98pp
- 机构数量
- 710 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund74.71%
Hedge Fund13.67%
VC/PE Fund4.03%
Individual/Insider3.47%
Private Company2.97%
Public Company2.92%
Sovereign Wealth Fund1.16%
Government Pension Fund1.11%
Insurance Company0.20%
主要股东 截至 2026-06-30
BlackRock
5.68% · 7.62M 股
Vanguard Capital Management, LLC
4.92% · 6.60M 股
T. Rowe Price Group, Inc.
4.85% · 6.51M 股
Vanguard Portfolio Management, LLC
4.06% · 5.45M 股
FMR
3.99% · 5.35M 股
Invesco Ltd.
3.07% · 4.11M 股
Two Sigma Investments, LP
2.77% · 3.72M 股
Capital Research
2.53% · 3.40M 股
Deep Track Capital, LP
2.53% · 3.39M 股
Columbia Management Investment Advisers, LLC
2.35% · 3.15M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 20次买入 · 30次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | 1.70% |
| AmirAli Talasaz | Co-Chief Executive Officer | 1.40% |
| Darya Chudova | Chief Technology Officer | 0.06% |
| Craig Eagle | Chief Medical Officer | 0.05% |
| Christopher Freeman | Chief Commercial Officer | 0.05% |
| Michael Bell | Chief Financial Officer | 0.04% |
| Kumud Kalia | Chief Information Officer | 0.03% |
| John Saia | Chief Legal Officer | 0.03% |
| Vijaya Gadde | Independent Director | 0.02% |
| Terilyn Monroe | Chief Human Resources Officer | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Kumud Kalia | Chief Information Officer | Derivative Exercise and Sale | -3,067 | $174.75 |
| 2026-09-30 | Kumud Kalia | Chief Information Officer | Derivative Exercise and Retained | +2,979 | -- |
| 2026-09-30 | Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | Derivative Exercise and Sale | -18,515 | $174.75–178.36 |
| 2026-09-30 | Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | Derivative Exercise and Retained | +18,015 | -- |
| 2026-09-30 | Michael Bell | Chief Financial Officer | Derivative Exercise and Sale | -3,914 | $174.75 |
| 2026-09-30 | Michael Bell | Chief Financial Officer | Derivative Exercise and Retained | +3,366 | -- |
| 2026-09-30 | AmirAli Talasaz | Co-Chief Executive Officer | Derivative Exercise and Sale | -18,515 | $174.75–178.36 |
| 2026-09-30 | AmirAli Talasaz | Co-Chief Executive Officer | Derivative Exercise and Retained | +18,015 | -- |
| 2026-09-30 | Terilyn Monroe | Chief Human Resources Officer | Derivative Exercise and Sale | -2,098 | $174.75 |
| 2026-09-30 | Terilyn Monroe | Chief Human Resources Officer | Derivative Exercise and Retained | +1,921 | -- |
| 2026-09-30 | John Saia | Chief Legal Officer | Derivative Exercise and Sale | -3,706 | $174.75 |
| 2026-09-30 | John Saia | Chief Legal Officer | Derivative Exercise and Retained | +3,357 | -- |
| 2026-09-30 | Christopher Freeman | Chief Commercial Officer | Derivative Exercise and Sale | -3,143 | $174.75 |
| 2026-09-30 | Christopher Freeman | Chief Commercial Officer | Derivative Exercise and Retained | +4,273 | -- |
| 2026-09-30 | Darya Chudova | Chief Technology Officer | Derivative Exercise and Sale | -4,320 | $174.75 |
| 2026-09-30 | Darya Chudova | Chief Technology Officer | Derivative Exercise and Retained | +3,713 | -- |
| 2026-09-20 | Roberto Mignone | Director | Derivative Exercise and Retained | +264 | -- |
| 2026-09-16 | Manuel Hidalgo Medina | Director | Derivative Exercise and Retained | +232 | -- |
| 2026-09-15 | Steve Krognes | Independent Director | Open Market Disposition | -6,674 | $174.46–177.48 |
| 2026-09-15 | Alex Azar | Director | Open Market Disposition | -826 | $175.00 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:21 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
守护者健康 讨论区 0 条评论